Local Management of Oligometastases in Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Riudavets Melia, M. [1 ]
Del Carpio Huerta, L. [1 ]
Barba Joaquin, A. [1 ]
Anguera Palacios, G. [1 ]
Sullivan, I. [1 ]
Callejo Perez, A. [1 ]
Farre, N. [2 ]
Torrego, A. [3 ]
Pajares, V. [3 ]
Martinez, E. [4 ]
Trujillo, J. C. [4 ]
De Quinana, C. [5 ]
Majem Tarruella, M. [1 ]
机构：
[1] Hosp La Santa Creu & St Pau, Med Oncol, Barcelona, Spain
[2] Hosp La Santa Creu & St Pau, Radiat Oncol, Barcelona, Spain
[3] Hosp La Santa Creu & St Pau, Pneumol, Barcelona, Spain
[4] Hosp La Santa Creu & St Pau, Orac Surg, Barcelona, Spain
[5] Hosp La Santa Creu & St Pau, Neurosurg, Barcelona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Non-Small Cell Lung Cancer; Oligometastases; Management;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-072
引用
收藏
页码：S2095 / S2095
页数：1
相关论文
共 50 条
  • [41] An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
    Murphy, Ciara
    Gornes Pons, Gloria
    Keogh, Anna
    Ryan, Lisa
    Mccarra, Lorraine
    Jose, Chris Maria
    Kesar, Shagun
    Nicholson, Siobhan
    Fitzmaurice, Gerard J.
    Ryan, Ronan
    Young, Vincent
    Cuffe, Sinead
    Finn, Stephen P.
    Gray, Steven G.
    BIOMEDICINES, 2023, 11 (09)
  • [42] Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)
    Gerald Schmid-Bindert
    Targeted Oncology, 2013, 8 : 15 - 26
  • [43] Mobocertinib in non-small cell lung cancer
    Liu, Shengwu
    Lowder, Kristen E.
    DRUGS OF TODAY, 2022, 58 (11) : 523 - 530
  • [44] Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC)
    Grossi, Francesco
    Tiseo, Marcello
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (03) : 221 - 230
  • [45] Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
    Guo, Shicheng
    Yan, Fengyang
    Xu, Jibin
    Bao, Yang
    Zhu, Ji
    Wang, Xiaotian
    Wu, Junjie
    Li, Yi
    Pu, Weilin
    Liu, Yan
    Jiang, Zhengwen
    Ma, Yanyun
    Chen, Xiaofeng
    Xiong, Momiao
    Jin, Li
    Wang, Jiucun
    Clinical Epigenetics, 2015, 7 : 2 - 9
  • [46] Individualized therapy in the adjuvant setting for non-small cell lung cancer (NSCLC)
    Celine Mascaux
    Simon Ekman
    Christophe Dooms
    Frances A. Shepherd
    Current Respiratory Care Reports, 2013, 2 (1): : 1 - 9
  • [47] Phase II study of mitonafide in non-small cell lung cancer (NSCLC)
    Casado, A
    Rosell, R
    GarciaGomez, R
    DiazRubio, E
    PerezManga, G
    Font, A
    Benavides, A
    Martin, M
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (04) : 415 - 417
  • [48] Management of stage III non-small cell lung cancer
    Tabchi, Samer
    Kassouf, Elie
    El Rassy, Elie
    Kourie, Hampig Raphael
    Martin, Jocelyne
    Campeau, Marie-Pierre
    Tehfe, Mustapha
    Blais, Normand
    SEMINARS IN ONCOLOGY, 2017, 44 (03) : 163 - 177
  • [49] Surgical Management of Oligometastatic Non-Small Cell Lung Cancer
    Lanuti, Michael
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 287 - +
  • [50] Management of oligoprogression in non-small cell lung cancer patients
    Tartarone, Alfredo
    Lerose, Rosa
    Tartarone, Marina
    MEDICAL ONCOLOGY, 2022, 39 (05)
12345